Brenner v. Manson
| Brenner v. Manson | |
|---|---|
| Argued November 17, 1965 Decided March 21, 1966 | |
| Full case name | Brenner, Commissioner of Patents v. Manson |
| Citations | 383 U.S. 519 (more) |
| Case history | |
| Prior | In re Manson, 333 F.2d 234 (C.C.P.A. 1964); cert. granted, 380 U.S. 971 (1965). |
| Court membership | |
| |
| Case opinions | |
| Majority | Fortas, joined by Warren, Black, Clark, Brennan, Stewart, White |
| Dissent | Harlan, joined by Douglas |
| Laws applied | |
| 35 U.S.C. § 101 | |
Brenner v. Manson, 383 U.S. 519 (1966), was a decision of the United States Supreme Court in which the Court held that a novel process for making a known steroid did not satisfy the utility requirement, because the patent applicants did not show that the steroid served any practical function. The Court ruled that "a process patent in the chemical field, which has not been developed and pointed to the degree of specific utility, creates a monopoly of knowledge which should be granted only if clearly commanded by the statute." Practical or specific utility, so that a "specific benefit exists in currently available form" is thus the requirement for a claimed invention to qualify for a patent.
The case is known for the statement "a patent is not a hunting license."